Cytosorbents Corp - Common Stock (CTSO)

CUSIP: 23283X206

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 6 signals
Share change
+2,957,414
SEC-reported price per share
$1.11
Indexed holders
52
Value change
+$3,216,187
Number of buys
20
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
63,013,241

Security key

23283X206

Report period

Q4 2023

Indexed institutions

52

Top holders

10

Ownership snapshot

Top reported holders of CTSO - Cytosorbents Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Skylands Capital, LLC
Disclosed value leader
Skylands Capital, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F 3/4/5 Highest disclosed value: $5,535,980 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Skylands Capital, LLC has the largest disclosed position value at $5.54M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Skylands Capital, LLC's linked filing trail.
Disclosed position value Top 5
Skylands Capital, LLC $5.54M
AVENIR CORP $5.11M
VANGUARD GROUP INC $3.67M
Granahan Investment Management, LLC $2.92M
Neuberger Berman Group LLC $2.82M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Skylands Capital, LLC
13F
Company
13F
—
denominator unverified
$5,535,980
2,944,670 shares
— 30 Sep 2023
AVENIR CORP
13F
Company
13F
—
denominator unverified
$5,108,706
2,717,397 shares
— 30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$3,665,156
1,949,551 shares
— 30 Sep 2023
Granahan Investment Management, LLC
13F
Company
13F
—
denominator unverified
$2,918,499
1,552,393 shares
— 30 Sep 2023
Neuberger Berman Group LLC
13F
Company
13F
—
denominator unverified
$2,821,112
1,502,696 shares
— 30 Sep 2023
Sargent Investment Group, LLC
13F
Company
13F
—
denominator unverified
$2,363,250
1,257,048 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
52
Shares
18,066,999
Indexed holders
52
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
52
Q4 2023 indexed holders
52
Indexed holder difference
0
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .